Aquinox to Participate in Two Upcoming Investor Events
10 déc. 2015 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Dec. 10, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Reports Third Quarter 2015 Financial Results
10 nov. 2015 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Results From Phase 2 KINSHIP Trial With AQX-1125 in Patients With Atopic Dermatitis
02 nov. 2015 20h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Nov. 02, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing...
Aquinox to Host R&D Day in New York
21 sept. 2015 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Sept. 21, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Presents at 2015 International Society for the Study of BPS Conference
18 sept. 2015 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Sept. 18, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Announces Closing of $98.0 Million Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
16 sept. 2015 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Sept. 16, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Prices Public Offering of Common Stock
09 sept. 2015 22h10 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Sept. 9, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Proposed Public Offering of Common Stock
08 sept. 2015 16h01 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Sept. 8, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
LEADERSHIP Results Accepted for Podium Presentation at the 2015 Annual Meeting of the International Society for the Study of BPS (ESSIC)
25 août 2015 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Aug. 25, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Positive Results From Secondary Endpoints From Phase 2 LEADERSHIP Trial in BPS/IC and Reports Second Quarter 2015 Financial Results
06 août 2015 16h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Aug. 6, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...